Synopsis
VERDICT (Vascular, Extracellular, and Restricted Diffusion
for Cytometry in Tumours) is a microstructural imaging technique that has shown
significant potential in preclinical and pilot studies. However, its technical
repeatability is unknown and must be established for translational and clinical
application.
5 patients underwent consecutive VERDICT acquisitions, and
their quantitative parametric maps were compared in tumour and non-tumour regions.
We found that cellularity was the most reliable parameter, with almost perfect repeatability
in both normal and cancerous prostate tissue. Intra and extracellular volume fractions
also performed well, with almost perfect repeatability in the normal prostate
and excellent repeatability in cancerous tissue.
Purpose
VERDICT (Vascular, Extracellular, and Restricted Diffusion for Cytometry in Tumours) is a microstructural imaging technique that combines a detailed diffusion MRI acquisition with a mathematical model to map and measure microstructural tissue parameters. The technique has shown significant promise in the preclinical setting1 and in a pilot study in prostate cancer2, but to develop the technique for translational and clinical research it must demonstrate technical validity.
This study seeks to evaluate the short-term repeatability of VERDICT MRI in normal and cancerous prostate tissue.
Methods
5 men awaiting biopsy for suspected prostate cancer were
identified and recalled for VERDICT MRI, with a median of 120 days (range 43-
151) from their original multiparametric prostate MRI.
VERDICT DW-MRI was performed using a 3T scanner (Achieva, Philips Healthcare, Netherlands) using a series of pulse-gradient
spin-echo sequences with various diffusion gradient strengths and timings3. The
series of scans was repeated following a 2-minute interval. Imaging
parameters are shown in Figure 1.
Diffusion
model
VERDICT
is a three-compartment model that characterises diffusion in the vascular,
extracellular-extravascular space (EES) and intracellular (IC) compartments in
tumours. The prostate model has five parameters: fEES (EES volume
fraction), fIC (IC volume fraction), cell radius R diffusivity
D and pseudo-diffusion P. Vascular volume fraction can
be determined from fVASC=1- fIC- fEES. Cellularity
maps are calculated by dividing fIC by the cell radius estimate cubed.
Image analysis
MR datasets were analysed with Osirix Version 7.0
(Bernex, Switzerland). A board certified Radiologist (EJ) manually contoured a
region of interest (ROI) on each prostate lesion, using the slice at the
epicentre of the tumour. ROIs were drawn on the b=2000s/mm2 image, using the
previous mpMRI for further guidance. An ROI of equal size was then drawn in a
normal region of the prostate, on the same slice in the same zone. ROIs were
copied onto the subsequent acquisition and manually refined accordingly.
We fitted the VERDICT model to the data using a
similar iterative optimization procedure to Panagiotaki et al.1,2 that
accounts for local minima and Rician noise. Fitting consisted in two steps,
first the model was fitted to data averaged over all voxels of the prostate
(tumor and benign regions) and then the fitting was performed in each
voxel. Fitting was performed using the open source
Camino toolkit4. Apparent diffusion coefficient
(ADC) was also fitted for comparison.
An example of a multi-parametric (mp)MRI and the subsequent generated
VERDICT maps are provided in Figure 2.
Statistical analysis
Median ROI values were used for all parameters, as data was
not normally distributed. Bland Altman plots were constructed and intraclass
correlation coefficients (ICCs) (3,1) single measures, with absolute agreement
calculated.
Results
5 patients had a median age of 67.4 (range 58.0 – 74.6), a
median prostate specific antigen (PSA) of 8.5 (range 3.3 – 18.0). Subsequent
biopsy performed within a week of the scan confirmed prostate cancer in the
peripheral zone (n=4) and transition zone (n=1), with Gleason scores of 3+3(n
=1) and 3+4 (n=4).
Bland-Altman plots were constructed and are interpreted in Figure 3.
Intraclass correlation coefficients (ICCs) are provided in Figure 4. In accordance with Landis and
Koch5, the following ICC interpretation scale was used: poor to fair
(below 0.4), moderate (0.41–0.60), excellent (0.61–0.80), and almost perfect
(0.81–1).
Discussion
To be clinically useful, any quantitative imaging technique
must demonstrate accurate estimates of the measured biological parameter
(accuracy) and be repeatable (precision)6.
Broadly, more complex biophysical models such as VERDICT
provide a better fit to data than simpler models with fewer parameters, such as
ADC, and our previous work has shown this to be the case1,2. However, more
complex models also tend to ‘overfit’ data, and become sensitive to noise,
resulting in poor repeatability.
In this study, we were able to compare the repeatability of
parametric maps generated from VERDICT MRI to those of ADC. As expected, ADC
demonstrated almost perfect agreement.
Cellularity was the most reliable parameter with almost
perfect agreement in both normal and cancerous prostate tissue. fIC and fEES were
the next best performing, demonstrating almost perfect agreement in the normal
prostate and excellent agreement in cancerous tissue.
However, cell radius and fvasc demonstrated poor to moderate
repeatability, with the latter likely due to relatively low contribution to MR
signal.
Conclusion
Cellularity, fEES and fIC are repeatable VERDICT parameters, but fvasc and cell radius show poor repeatability.
Further work is required to establish the medium and long-term repeatability of
VERDICT, and for biological validation to determine what constitutes a
clinically useful measurement.
Acknowledgements
This work is funded by a grant from Prostate Cancer UK. A grant from the Biomedical Research Council supports EJ and
SP’s work on this topic. EPSRC grants G007748 and H046410 support DA, EBC, and EP’s work on this topic. References
1. Panagiotaki
E, Walker-Samuel S, Siow B, et al. Noninvasive quantification of solid tumor
microstructure using VERDICT MRI. Cancer Res. 2014 Apr 1;74(7):1902-12
2. Panagiotaki
E, Chan RW, Dikaios N, et al. Microstructural Characterization of Normal and
Malignant Human Prostate Tissue With Vascular , Extracellular , and Restricted
Diffusion for Cytometry in Tumours Investigative Radiology, 50
(4), 218-227.
3. Panagiotaki E, Ianus A, Johnston E et. al, Optimised
VERDICT MRI protocol for prostate cancer characterisation. 24th Scientific Meeting
of the International Society for
Magnetic Resonance in Medicine, Toronto, Canada 2015.
4. P. A. Cook, Y.
Bai, S. Nedjati-Gilani, K. et. al, Camino:
Open-Source Diffusion-MRI Reconstruction and Processing, 14th Scientific Meeting of the International Society for
Magnetic Resonance in Medicine, Seattle, WA, USA, p. 2759, May 2006.
5. Landis JR, Koch GG. The
measurement of observer agreement for categorical data. Biometrics 1977;33:159-174.
6. Tofts P.
QA: quality assurance, accuracy, precision and phantoms. 2003; Available from: http://discovery.ucl.ac.uk/188427/.
Accessed 8th November 2015.